INNO InnoCan Pharma Corporation

1.950CAD0.00%Mkt Cap: 6.39M $P/E: —

InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company …

Key Statistics

Company
Market Cap6.39M USD
Enterprise Value4.84M USD
Revenue (TTM)17.13M USD
Gross Profit17.43M USD
Net Income (TTM)-818.57K USD
Revenue/Share5.24 CAD
Last Price1.950 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorConsumer Defensive
IndustryHousehold & Personal Products
ISINCA45783P1027
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.96
EV/Revenue0.28
P/S0.37
P/B1.30
EPS (TTM)-0.36
EPS (Forward)—
52W Range
1.9500% of range21.00
52W High21.00 CAD
52W Low1.950 CAD
Profitability
Gross Margin89.93%
Oper. Margin-9.68%
EBITDA Margin-14.44%
Profit Margin-4.22%
ROE-20.08%
ROA-10.68%
Growth
Revenue Growth-25.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF360.49K USD
CapEx (TTM)11.65K USD
FCF Margin-9.97%
FCF Yield-26.75%
Net Debt-3.45M USD
Net Debt/EBITDA1.39
Balance Sheet
Debt/Equity0.17
Current Ratio5.25
Quick Ratio3.78
Book Value/Sh1.50 CAD
Cash/Share1.42 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:65
Split DateSep 5, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.50M
Float3.58M
Insiders19.26%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Out.0.01%
Shares Short382
Short (prev mo.)72
Technical
SMA 502.326 (-16.2%)
SMA 2004.903 (-60.2%)
Beta0.30
S&P 52W Chg16.45%
Avg Vol (30d)499
Avg Vol (10d)226
Technical Indicators
RSI (14)29.6
MACD-0.2968
MACD Signal-0.2799
MACD Hist.-0.0170
BB Upper3.211 CAD
BB Middle2.441 CAD
BB Lower1.670 CAD
BB Width63.13%
ATR (14)0.1174 CAD
Vol Ratio (20d)0.00x